Jul 10, 2015 9:25am EDT OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient Adults
Jul 10, 2015 9:00am EDT OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
Jul 02, 2015 11:10am EDT OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition
Jun 26, 2015 10:25am EDT OPKO 4Kscore® Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection
Jun 09, 2015 11:54am EDT OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress on Its Long-Acting Clotting Factor VIIa
Jun 08, 2015 8:00am EDT OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger
May 29, 2015 2:42pm EDT OPKO Announces Submission of Rayaldee™ New Drug Application to U.S. Food and Drug Administration
May 18, 2015 9:21am EDT OPKO Announces 4Kscore® Abstracts at the 2015 American Urological Association (AUA) Annual Meeting